Gottschalk-Sabag S, Ron N, Glick T
Department of Pathology, Shaare Zedek Medical Center, Jerusalem, Israel.
Acta Cytol. 1998 May-Jun;42(3):691-6. doi: 10.1159/000331828.
The immunohistochemical staining patterns characteristic of hepatocellular carcinoma (HCC) using CD34 and factor VIII antibodies were compared with those of other hepatic lesions to determine if these stainings can be used as a diagnostic criterion.
We reviewed 44 fine needle aspirates from the liver to evaluate the immunoperoxidase staining patterns on cell block preparations using CD34 and factor VIII and to determine whether this could distinguish HCC from the other lesions. These included HCC (14 cases), metastatic tumor (14 cases) and nonneoplastic liver lesions (16 cases).
This retrospective study showed that in the nine documented cases of HCC, staining for CD34 and/or factor VIII was positive. The pattern of staining was either peripheral, around small clusters of tumor cells, or linear, diffuse and sinusoidal. In all the documented cases (27) of metastatic carcinoma and nonneoplastic lesions staining for CD34 and factor VIII was negative. In addition, there were eight problematic cases. In 7 cases the cytologic diagnosis on Papanicolaou-stained smears was inconclusive about HCC or metastatic carcinoma. CD34 and factor VIII confirmed the final diagnosis on the cell blocks. Based on this staining, 4 were HCC, 2 were metastatic carcinoma and 1 was equivocal, most probably HCC. In one case the differential diagnosis between well-differentiated HCC and a nonneoplastic liver lesion could not be made on cytologic smears, and here, also, CD34 and factor VIII aided in the correct diagnosis of a nonneoplastic liver lesion.
We suggest immunoperoxidase staining with CD34 and factor VIII be performed on the cell block sections from FNAs in any problematic hepatic case.
比较使用CD34和因子VIII抗体时肝细胞癌(HCC)的免疫组化染色模式与其他肝脏病变的染色模式,以确定这些染色是否可作为诊断标准。
我们回顾了44例肝脏细针穿刺抽吸物,以评估使用CD34和因子VIII对细胞块标本进行免疫过氧化物酶染色的模式,并确定这是否能将HCC与其他病变区分开来。这些病例包括HCC(14例)、转移性肿瘤(14例)和非肿瘤性肝脏病变(16例)。
这项回顾性研究表明,在9例记录在案的HCC病例中,CD34和/或因子VIII染色呈阳性。染色模式要么是周边性的,围绕小簇肿瘤细胞,要么是线性、弥漫性和窦状的。在所有记录在案的转移性癌(27例)和非肿瘤性病变病例中,CD34和因子VIII染色均为阴性。此外,有8例疑难病例。在7例病例中,巴氏染色涂片的细胞学诊断对HCC或转移性癌无法确诊。CD34和因子VIII在细胞块上确定了最终诊断。基于这种染色,4例为HCC,2例为转移性癌,1例不明确,很可能是HCC。在1例病例中,细胞学涂片无法对高分化HCC和非肿瘤性肝脏病变进行鉴别诊断,在此,CD34和因子VIII也有助于正确诊断非肿瘤性肝脏病变。
我们建议,对于任何疑难肝脏病例的细针穿刺抽吸物的细胞块切片,都应进行CD34和因子VIII免疫过氧化物酶染色。